Literature DB >> 17549006

RNA in brain disease: no longer just "the messenger in the middle".

Peter T Nelson1, Jeffrey N Keller.   

Abstract

RNA research has made great progress in recent years. A variety of unforeseen complexities have been identified, many with relevance to human brain disease. For example, neurologic illnesses may arise because of perturbations in distinct but interrelated tiers of RNA-based genetic regulation: pre-mRNA splicing; nonsplicing RNA modifications; and mRNA translational regulation. Furthermore, there is poor correlation between mRNA levels and protein levels in mammalian cells, due partly to complicated post-transcriptional regulation by hitherto unknown noncoding RNAs. Some noncoding RNAs have been shown to be involved in human brain diseases. Diseases potentially mediated by alterations in RNA processes include tauopathies, myotonic dystrophy, Alzheimer disease, brain cancer, and many others. Here we present an overview of new research highlighting functions for RNA that far surpass the "messenger in the middle" role and that identify RNA molecules as important agents in the human brain in health and in disease states.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17549006     DOI: 10.1097/01.jnen.0000240474.27791.f3

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  56 in total

1.  Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features.

Authors:  Allison A Curley; Dominique Arion; David W Volk; Josephine K Asafu-Adjei; Allan R Sampson; Kenneth N Fish; David A Lewis
Journal:  Am J Psychiatry       Date:  2011-06-01       Impact factor: 18.112

2.  The crystal structure of Mtr4 reveals a novel arch domain required for rRNA processing.

Authors:  Ryan N Jackson; A Alejandra Klauer; Bradley J Hintze; Howard Robinson; Ambro van Hoof; Sean J Johnson
Journal:  EMBO J       Date:  2010-05-28       Impact factor: 11.598

Review 3.  Epigenetic control of aging.

Authors:  Ursula Muñoz-Najar; John M Sedivy
Journal:  Antioxid Redox Signal       Date:  2010-11-22       Impact factor: 8.401

Review 4.  ABCC9/SUR2 in the brain: Implications for hippocampal sclerosis of aging and a potential therapeutic target.

Authors:  Peter T Nelson; Gregory A Jicha; Wang-Xia Wang; Eseosa Ighodaro; Sergey Artiushin; Colin G Nichols; David W Fardo
Journal:  Ageing Res Rev       Date:  2015-07-28       Impact factor: 10.895

Review 5.  Technical variables in high-throughput miRNA expression profiling: much work remains to be done.

Authors:  Peter T Nelson; Wang-Xia Wang; Bernard R Wilfred; Guiliang Tang
Journal:  Biochim Biophys Acta       Date:  2008-04-07

6.  An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells.

Authors:  Walter J Lukiw; Yuhai Zhao; Jian Guo Cui
Journal:  J Biol Chem       Date:  2008-09-18       Impact factor: 5.157

7.  Tumour necrosis factor-α (TNF-α) and miRNA expression in frontal and temporal neocortex in Alzheimer's disease and the effect of TNF-α on miRNA expression in vitro.

Authors:  Doris Culpan; Patrick G Kehoe; Seth Love
Journal:  Int J Mol Epidemiol Genet       Date:  2011-03-25

Review 8.  Diverse deafness mechanisms of connexin mutations revealed by studies using in vitro approaches and mouse models.

Authors:  Emilie Hoang Dinh; Shoeb Ahmad; Qing Chang; Wenxue Tang; Benjamin Stong; Xi Lin
Journal:  Brain Res       Date:  2009-02-20       Impact factor: 3.252

9.  MicroRNA and mRNA integrated analysis (MMIA): a web tool for examining biological functions of microRNA expression.

Authors:  Seungyoon Nam; Meng Li; Kwangmin Choi; Curtis Balch; Sun Kim; Kenneth P Nephew
Journal:  Nucleic Acids Res       Date:  2009-05-06       Impact factor: 16.971

10.  MicroRNA: An emerging therapeutic target and intervention tool.

Authors:  Zhen Liu; Alhousseynou Sall; Decheng Yang
Journal:  Int J Mol Sci       Date:  2008-06-13       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.